149(top 1%)
papers
11.2K(top 1%)
citations
47(top 1%)
h-index
106(top 1%)
g-index
168
all documents
12.6K
doc citations
1.5K
citing journals

Top Articles

#TitleJournalYearCitations
1Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialNew England Journal of Medicine20121,699
2Co-evolution of a broadly neutralizing HIV-1 antibody and founder virusNature2013961
3Immunosenescence of ageingJournal of Pathology2007730
4Structure and immune recognition of trimeric pre-fusion HIV-1 EnvNature2014702
5HIV‐1 neutralizing antibodies: understanding nature's pathwaysImmunological Reviews2013442
6Thymic involution and immune reconstitutionTrends in Immunology2009428
7Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After VaccinationScience Translational Medicine2014412
8Controlling the SARS-CoV-2 spike glycoprotein conformationNature Structural and Molecular Biology2020376
9Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 VaccinesScience Translational Medicine2014367
10Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicityScience2021318
11Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsCell2015305
12Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing AntibodiesCell2014266
13D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 JunctionCell Reports2021263
14Human Responses to Influenza Vaccination Show Seroconversion Signatures and Convergent Antibody RearrangementsCell Host and Microbe2014246
15A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNature Medicine2018235
16Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodiesScience Translational Medicine2017212
17Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-LifeFrontiers in Immunology2019211
18Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionNature Medicine2016197
19Cytokines, leptin, and stress-induced thymic atrophyJournal of Leukocyte Biology2008179
20Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine DesignJournal of Virology2012159
21The SARS-CoV-2 Spike variant D614G favors an open conformational stateScience Advances2021156
22HIV-Host Interactions: Implications for Vaccine DesignCell Host and Microbe2016143
23Immunoglobulin Gene Insertions and Deletions in the Affinity Maturation of HIV-1 Broadly Reactive Neutralizing AntibodiesCell Host and Microbe2014137
24Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) PandemicApplied Biosafety2020137
25Structural diversity of the SARS-CoV-2 Omicron spikeMolecular Cell2022125
26Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primatesProceedings of the National Academy of Sciences of the United States of America2011121
27Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodiesScience Immunology2016120
28Phenotypic and Functional Profile of HIV-Inhibitory CD8 T Cells Elicited by Natural Infection and Heterologous Prime/Boost VaccinationJournal of Virology2010110
29Complex immune correlates of protection in HIV‐1 vaccine efficacy trialsImmunological Reviews201795
30Leptin Selectively Augments Thymopoiesis in Leptin Deficiency and Lipopolysaccharide-Induced Thymic AtrophyJournal of Immunology200690
31Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPsBlood Advances201790
32Inflammation Triggers Emergency Granulopoiesis through a Density-Dependent Feedback MechanismPLoS ONE201186
33Dysregulated transcriptional responses to SARS-CoV-2 in the peripheryNature Communications202181
34Multiple HIV-1-specific IgG3 responses decline during acute HIV-1Aids201179
35Thymic rejuvenation and agingCurrent Opinion in Immunology201379
36Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spikeCell Reports202274
37DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challengeProceedings of the National Academy of Sciences of the United States of America201371
38Germinal center entry not selection of B cells is controlled by peptide-MHCII complex densityNature Communications201871
39Host controls of HIV broadly neutralizing antibody developmentImmunological Reviews201765
40Cold sensitivity of the SARS-CoV-2 spike ectodomainNature Structural and Molecular Biology202165
41Acute Endotoxin-Induced Thymic Atrophy Is Characterized By Intrathymic Inflammatory and Wound Healing ResponsesPLoS ONE201162
42Two Genes on A/J Chromosome 18 Are Associated with Susceptibility to Staphylococcus aureus Infection by Combined Microarray and QTL AnalysesPLoS Pathogens201061
43Immunologic characteristics of HIV‐infected individuals who make broadly neutralizing antibodiesImmunological Reviews201758
44Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy TrialJournal of Infectious Diseases201757
45Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodiesCell202157
46Initial HIV-1 Antigen-Specific CD8 + T Cells in Acute HIV-1 Infection Inhibit Transmitted/Founder Virus ReplicationJournal of Virology201256
47Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01Cell Host and Microbe201956
48Influenza and Antibody-Dependent Cellular CytotoxicityFrontiers in Immunology201955
49Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization FingerprintingPLoS Pathogens201751
50A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped virusesPeptides201346